Unicycive Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Unicycive Therapeutics, Inc. (“Unicycive Therapeutics” or “the Company”) (NASDAQ: UNCY) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Unicycive Therapeutics investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Inve ...